Medicis Pharmaceutical Corp had sued Mylan, Teva Pharma, Barr Laboratories and other companies to block generic versions of Medicis’s Minocycline Hydrochloride (Solodyn) acne drug.
Medicis said the generic version of the drug would violate a patent and also named Sandoz AG and Mylan’s Matrix Laboratories unit in a complaint filed yesterday in federal court in Delaware. Medicis, based in Scottsdale, Arizona, is seeking an order stopping the rival drugmakers from producing and marketing the treatment and unspecified damages.
Full article Here
No comments:
Post a Comment